You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 2, January 8, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Landmark Perspective
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Hypertension Detection and Follow-up Program

17 Years On

Lawrence E. Ramsay, MB ChB, FRCP

JAMA. 1997;277(2):167-170.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Hypertension Detection and Follow-up Program (HDFP)1 was a remarkable feat of clinical investigation that tackled an important question. The study design was a gamble—a $60 million gamble2—that paid off. A respectable difference in diastolic blood pressure (DBP) between stepped care (SC) and referred care (RC) groups was crucial for this massive undertaking to succeed. In fact, the net DBP difference was "only" 5 to 6 mm Hg over the 5 years, but we now know that this is identical to the net DBP difference in all conventionally designed controlled trials of antihypertensive drugs.3 Allcause mortality, the principal end point, was reduced in all SC subjects by 17% (P<.01), and by 20% (P<.01) in those with initial DBP of 90 to 104 mm Hg. Treatment of 66 subjects with DBP 90 to 104 mm Hg for 5 years prevented 1 death, a return that compares favorably . . . [Full Text PDF of this Article]


Author Affiliations

From the Section of Clinical Pharmacology and Therapeutics, Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield, England.


Footnotes

A commentary on Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, I: reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242:2562-2571.

Reprints: Professor L. E. Ramsay, Section of Clinical Pharmacology and Therapeutics, Department of Medicine and Pharmacology, L Floor, Royal Hallamshire-Hospital, Glossop Road, Sheffield S10 2JF, England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.